Peptide Protocols: Metabolic Repair at the Molecular Level in Neurodegeneration
Dr. Uladzislau Tsvirko
15 January 2025
Motor neurons under degenerative stress require enormous energy to function while their mitochondria are compromised. Peptide therapy targets this metabolic crisis directly — restoring cellular energy production where it matters most.
The Metabolic Dimension of Neurodegeneration
Neurodegenerative disease is not purely an inflammatory or immune-mediated process. At the cellular level, neurons under degenerative stress exhibit profound metabolic dysfunction: compromised mitochondria, excessive reactive oxygen species production, impaired protein homeostasis, and declining ATP output. This metabolic crisis is both a consequence of disease and an accelerant of further degeneration. Cells cannot maintain their function — or respond effectively to regenerative intervention — without adequate metabolic support. Peptide protocols address this dimension directly.
Bioactive Peptides as Signalling Molecules
Bioactive peptides are short-chain molecules (2–50 amino acids) that function as intercellular signalling agents. They bind to specific cell-surface receptors or intracellular targets, triggering downstream signalling cascades with high specificity. Unlike whole proteins, peptides are small enough to achieve rapid cellular uptake and targeted molecular interaction. Their selectivity allows precise intervention in specific metabolic pathways — a degree of molecular targeting that broader pharmacological agents cannot achieve.
Targeted Pathway Modulation
Depending on the peptide combination selected, four primary molecular pathways can be addressed. Mitochondrial peptides (SS-31 analogues) restore electron transport chain efficiency and reduce reactive oxygen species production. Anti-inflammatory peptides modulate NF-κB and JAK-STAT pathways, addressing chronic inflammatory signalling at its molecular origin. Neurotrophic peptides activate TrkB and CNTF receptors, promoting neuronal survival and axonal growth. Metabolic peptides improve overall cellular energy metabolism and protein homeostasis — supporting the fundamental capacity of neurons to function under disease conditions.
Individualised Formulation
Peptide selection at BioCells Medical begins with the patient’s metabolic assessment: blood biomarkers, mitochondrial function indicators, inflammatory panel, and nutritional status. The medical board selects a combination of 3–8 peptides from a library of validated bioactive sequences, targeting the specific metabolic imbalances and inflammatory patterns identified in each individual patient. Dosing is calculated based on body weight, metabolic status, and target pathways. Peptides are sourced from certified pharmaceutical-grade manufacturers with documented purity (>98%), identity verification by mass spectrometry, and stability testing.
The Multi-Scale Therapeutic Model
Peptides address the metabolic dimension of disease that cells alone cannot fully correct. They operate at the molecular level, complementing the cellular-level action of MSCs and T-regs and the circuit-level action of neurostimulation. The result is a multi-scale therapeutic approach: molecular repair (peptides), cellular regeneration (MSCs, T-regs, exosomes), and functional circuit activation (neurostimulation). Each level supports the others — peptides create the metabolic conditions for cells to function effectively, cells create the biological substrate for circuits to reconnect, and neurostimulation drives the functional integration of all preceding repair.